ASSURE Wearable ECG vs qXR-CTR
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A, the ASSURE Wearable ECG, is designed for continuous, real-time heart rate and ECG monitoring via a wearable device for at-risk cardiac patients. In contrast, Tool B, qXR-CTR, is an AI-powered software that automates the measurement of the cardiothoracic ratio from chest X-ray images to assess heart size. While both fall under Cardiology AI, they are not direct competitors as they address different data sources and clinical applications: continuous physiological monitoring versus static diagnostic image analysis.
Choose ASSURE Wearable ECG if…
Choose ASSURE Wearable ECG if you require continuous, real-time heart rate monitoring and detailed ECG data collection for at-risk cardiac patients. This tool is ideal for actively tracking patient physiology, receiving alert-based notifications for potential cardiac events, and reviewing long-term trend data through a remote patient data platform.
View ASSURE Wearable ECG →Choose qXR-CTR if…
Choose qXR-CTR if your primary need is automated, rapid assessment of heart size and potential heart failure risk directly from chest X-ray images. This AI-powered software is best suited for efficiently screening large volumes of X-rays to measure the cardiothoracic ratio, providing a quick initial indication for further cardiac evaluation.
View qXR-CTR →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | ASSURE Wearable ECG | qXR-CTR |
|---|---|---|
| Pricing | Contact for pricing. | Unknown |
| Deployment | Wearable device, mobile application, and cloud-based remote patient data platform. | Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | ASSURE Wearable ECG | qXR-CTR |
|---|---|---|
| Name | ASSURE Wearable ECG | qXR-CTR |
| Company | Kestra Medical Technologies | Qure.ai Technologies |
| Primary Function | Non-therapeutic device for continuous heart rate monitoring and data collection for at-risk cardiac patients. | AI-powered software that automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images. |
| Categories | Cardiology AI, Wearables & Remote Monitoring (RPM) | Cardiology AI, Radiology & Imaging AI |
| Specialties | Cardiology | Cardiology, Radiology |
| Key Features | Wearable ECG device for continuous heart rate monitoring; SensorFit Garment; ASSURE Detection Algorithm with Quad Channel Processingu2122; Adaptive Patient Intelligenceu2122 for filtering motion artifacts; Automatic episode storage; Alert-based notifications; Physiologic trend data; Kestra CareStation remote patient data platform for clinician review. | AI-powered automated cardiothoracic ratio (CTR) measurement from chest X-ray images; Aids in the assessment of heart size and potential heart failure risk. |
Videos
Demos, reviews, and walkthroughs featuring ASSURE Wearable ECG and qXR-CTR.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
Tool A, the ASSURE Wearable ECG, is a non-therapeutic wearable device for continuous heart rate monitoring and data collection in at-risk cardiac patients, providing physiologic trend data and alert-based notifications. Tool B, qXR-CTR, is an AI-powered software that automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk.
The ASSURE Wearable ECG system includes a wearable device, a mobile application, and a cloud-based remote patient data platform called Kestra CareStation for clinician review. qXR-CTR offers flexible deployment options including cloud, on-premise, or hybrid models, and integrates into existing radiology workflows to analyze chest X-ray images.
The ASSURE Wearable ECG provides continuous heart rate monitoring and ECG data, utilizing its ASSURE Detection Algorithm with Quad Channel Processing and Adaptive Patient Intelligence to filter motion artifacts. qXR-CTR specifically measures the cardiothoracic ratio from posterior-anterior chest X-ray images, providing an automated assessment of heart size to indicate potential heart failure risk.
Yes, the ASSURE Wearable ECG is a patient-worn device, featuring a SensorFit Garment with non-adhesive, embedded, and cushioned ECG sensors for continuous monitoring. In contrast, qXR-CTR is a software solution that analyzes chest X-ray images and does not require direct patient interaction beyond the standard X-ray imaging procedure itself.
The ASSURE Wearable ECG is primarily designed for cardiology, focusing on continuous monitoring for at-risk cardiac patients. qXR-CTR is beneficial for both cardiology and radiology, as it aids in assessing heart size from chest X-rays, which is relevant for both specialties.